From: Association between statin therapy and outcomes in critically ill patients: a nested cohort study
 | Statin therapy n = 107 | Non-statin therapy n = 656 | Adjusted odds ratio (aOR)a | 95% confidence interval | P-value |
---|---|---|---|---|---|
Sepsis, no.% | 32/107 (29.9) | 280/656 (42.7) | 0.84 | (0.51 - 1.37) | 0.49 |
   Dose < 40 mg | 16/47 (34.0) | 280/656 (42.7) | 1.11 | (0.57 - 2.20) | 0.74 |
   Dose ≥ 40 mg | 16/60 (25.7) | 280/656 (42.7) | 0.67 | (0.36 - 1.30) | 0.22 |
Severe sepsis, no. % | 26/107 (24.3) | 207/656 (31.6) | 0.87 | (0.51 - 1.50) | 0.60 |
   Dose < 40 mg | 11/47 (23.4) | 207/656 (31.6) | 0.88 | (0.42 - 1.90) | 0.74 |
   Dose ≥ 40 mg | 15/60 (25.0) | 207/656 (31.6) | 0.85 | (0.44 - 1.65) | 0.64 |
ICU LOS, mean ± SD, days | 10.2 ± 12.7 | 11.3 ± 10.6 | * | * | 0.33 |
Hospital LOS, mean ± SD, days | 67.6 ± 118.1 | 58.6 ± 81.4 | * | * | 0.37 |
MVD, mean ± SD, days | 9.0 ± 11.9 | 10.1 ± 10.3 | * | * | 0.33 |